TOPIGEN Pharmaceuticals Inc. signs a development and manufacturing agreement with DOW to supply oligonucleutides
11-Mar-2003 -
TOPIGEN Pharmaceuticals Inc. and The Dow Chemical Company recently signed a joint agreement for Dowpharma, Dow's pharmaceutical manufacturing services business unit, to supply select, proprietary oligonucleotides to TOPIGEN.
TOPIGEN's pharmaceutical development program, based primarily on a ...
asthma
business development
clinical trials
+10